Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Wallace

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Infectious Diseases (London, England)|August 15, 2017
Dalbavancin as a cost effective antibioticTara Nair, Jennifer Fitzgerald, Bob Ly, et al.
Current Infectious Disease Reports|March 10, 2006
Vaccination in patients with HIV infectionTodd D Gleeson, Mark R Wallace, Sybil A Tasker
Medicine|September 9, 2005
Infections associated with tumor necrosis factor-alpha antagonistsNancy F Crum, Edith R Lederman, Mark R Wallace
Scandinavian Journal of Infectious Diseases|February 18, 2003
Stenotrophomonas maltophilia endocarditisNancy F Crum, Gregory C Utz, Mark R Wallace
Journal of General Internal Medicine|June 16, 2021
Impact of Patient Portal Messaging Reminders with Self-Scheduling Option on Influenza Vaccination Rates: a Prospective, Randomized TrialBenjamin E Ueberroth, Helene R Labonte, Mark R Wallace
Reviews in Gastroenterological Disorders|August 24, 2007
New issues in infectious diarrheaNancy F Crum, Mark R Wallace, Edward C Oldfield
Southern Medical Journal|September 3, 2011
Staphylococcus lugdunensis: an emerging pathogenAlyona Klotchko, Mark R Wallace, Carmelo Licitra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 28, 2014
Tigecycline for severe Clostridium difficile infectionAshley Thomas, Farhan Khan, Nizam Uddin, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2016
Efficacy and Safety of Oral Fosfomycin for Urinary Tract Infections in Hospitalized PatientsShauna Jacobson, Luis Junco Noa, Syed Ahmed, et al.
Military Medicine|March 15, 2003
The effect of driving distance from medical treatment facility and short-term management outcomes in Department of Defense beneficiaries newly diagnosed with human immunodeficiency virusMark S Riddle, David L Blazes, Mark R Wallace, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Infectious Diseases (London, England)|August 15, 2017
Dalbavancin as a cost effective antibioticTara Nair, Jennifer Fitzgerald, Bob Ly, et al.
Current Infectious Disease Reports|March 10, 2006
Vaccination in patients with HIV infectionTodd D Gleeson, Mark R Wallace, Sybil A Tasker
Medicine|September 9, 2005
Infections associated with tumor necrosis factor-alpha antagonistsNancy F Crum, Edith R Lederman, Mark R Wallace
Scandinavian Journal of Infectious Diseases|February 18, 2003
Stenotrophomonas maltophilia endocarditisNancy F Crum, Gregory C Utz, Mark R Wallace
Journal of General Internal Medicine|June 16, 2021
Impact of Patient Portal Messaging Reminders with Self-Scheduling Option on Influenza Vaccination Rates: a Prospective, Randomized TrialBenjamin E Ueberroth, Helene R Labonte, Mark R Wallace
Reviews in Gastroenterological Disorders|August 24, 2007
New issues in infectious diarrheaNancy F Crum, Mark R Wallace, Edward C Oldfield
Southern Medical Journal|September 3, 2011
Staphylococcus lugdunensis: an emerging pathogenAlyona Klotchko, Mark R Wallace, Carmelo Licitra, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 28, 2014
Tigecycline for severe Clostridium difficile infectionAshley Thomas, Farhan Khan, Nizam Uddin, et al.
Antimicrobial Agents and Chemotherapy|February 28, 2016
Efficacy and Safety of Oral Fosfomycin for Urinary Tract Infections in Hospitalized PatientsShauna Jacobson, Luis Junco Noa, Syed Ahmed, et al.
Military Medicine|March 15, 2003
The effect of driving distance from medical treatment facility and short-term management outcomes in Department of Defense beneficiaries newly diagnosed with human immunodeficiency virusMark S Riddle, David L Blazes, Mark R Wallace, et al.
Pageof 7